Previous Pause Next
Home >> News Center >>
Airborne Fungi Linked to Asthma Epidemic in Puerto Rico PDF Print E-mail
User Rating :  / 0
Tuesday, 10 March 2009 07:40

A survey of airborne fungi and fungal spores found in Eastern Puerto Rico suggests that certain species may be a major cause of the high incidence of childhood asthma in this part of the world. A new article suggests this information could be used to alleviate human factors that lead to high levels of such fungi.

Worldwide asthma incidence has been on the increase since the latter part of the twentieth century. It is a chronic breathing disorder with both genetic and environmental factors influencing symptoms and no single known cause. According to the US Center for Disease Control, Puerto Rico has a higher overall prevalence of lifetime (19.6%) and current (11.6%) asthma than other parts of the Americas. Incidence among the under-eighteens is particularly high in the eastern part of the island.

Research suggests that interactions between genetic susceptibility and environmental triggers may be responsible for raised incidence in particular regions.

Alberto Rivera Rentas, now working at the National Institute of General Medical Sciences, at the National Institute of Health, in Bethesda, Maryland, working with Christian Velez of the Universidad Metropolitana of San Juan and Antonio Gonzalez of the Universidad del Turabo, in Gurabo, Puerto Rico, have now isolated and identified microbial fungi, which they suggest are linked to asthma.

They point out that allergens and pollution are undoubtedly important factors in the development of asthma, although they alone cannot be the sole cause of its increasing, widespread prevalence. In considering Puerto Rico, they suggest that no studies have so far investigated the particularly high incidence of the disorder there in an integrated way.

The team sampled air from eleven communities in the municipality of Caguas. From these samples they identified a total of 514 different fungi and correlated the general family groups, the fungal genus, with precise location. Using the Geographic Information Systems they could address factors of geology, geography, vegetation abundance, atmospheric conditions and human activities such as industry and vehicle traffic that might influence fungal distribution.

Airborne fungi are a potential health hazard to everyone. They can impact human health in four main ways: infecting people, acting as allergens, they can be toxic and carcinogenic, or they can cause inflammatory reactions.

Rivera Rentas and colleagues found that two particular fungal groups - Cladosporium and Mycelia sterilia were more common than others. When they classified the sampled regions they saw that four of the six locations sampled having the highest number of fungal colonies as urban. These developed areas have moderate to high vehicular traffic. The work provides evidence of asthma-related fungi in the area, although this alone does not account for the observed high asthma prevalence.

"This work revealed the presence of fungal allergens that can be potential asthma triggers and establishes a rationale for future research in this area," the researchers conclude.


Journal reference:

  1. Christian Velez, Antonio Gonzalez, and Alberto Rivera Rentas. Isolation and identification of airborne fungi that can cause asthma: a case study from Eastern Puerto Rico. International Journal of Environmental Technology and Management, 2009, 10, 243-259
Adapted from materials provided by Inderscience Publishers, via EurekAlert!, a service of AAAS.
 
FairExcellent 

Add comment  |   Add to my library  |  Forward this article

login to leave comment

Collaboration, Projects, & Consortia

Indiana Clinical and Translational Science Institute HUB: A model for collaboration

TGen, Karmanos Lead $6M Melanoma Project

Sanford-Burnham Medical Research Institute and Pfizer Collaborate to Speed Drug Discovery

e2v aerospace and defense and Maxim Announce an Agreement to Extend the Product Life of Maxim Ceramic ICs

Syntaxin and Ipsen Ally to Develop Botulinum Toxin Therapeutics

BioAmber and LANXESS Partner for Renewable, Phthalate-free Plasticizers

Corgenix Partners with AXA Diagnostics on SkyLAB 752™ Automated Testing Platform

GeoVax and Vivalis Sign Deal for the Biomanufacture of MVA HIV Vaccine in EB66 Cells

EMD Serono and Fast Forward Commit $3 Million for Multiple Sclerosis

VisionGate Begins Collaborations to Evaluate 3-D Cell Analysis Test for Lung Cancer Screening

>> More in: Collaboration, Projects and Consortia

Featured Experts

Featured Laboratories

Grant & Funding Opportunities

Federally funded research & development centers employed more than 3,000 postdoctoral researchers

Federally-funded Research and Development Centers Spend $17.8 Billion in Fiscal Year 2011

NHGRI Unveils New-Look Genome Sequencing Program; Plans $416M in Funding

NYU to Study Genetics of Obesity-Related Cancers

Researchers Get NHGRI Funding to Study Effects of Alzheimer's Risk Testing

Venture Firms Pump $18M into Fledgling Arteaus Therapeutics

Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics

Tetraphase Awarded Initial $6M by NIAID to Develop Antibiotic Against Biothreats

Dermira Announces a $42m Series A Financing to Fund Therapeutic Advances in Dermatology

Salk Institute for Biological Studies to Accelerate Brain Research With $4.5 Million National Institutes of Health (NIH) Grant

>> More in: Grant & Funding Opportunities

Appointments

Sanofi (France) Taps David Meeker as New CEO of Genzyme Corporation

Drug Information Association Appoints Kaushik Desai as DIA India Director

Sentrx Announces Resignation of Charles T. Saldarini As CEO

EKR Therapeutics Announces Senior Management Change

Amgen Appoints Robert A. Bradway to the Company's Board of Directors

Anavex Life Sciences Corp. Appoints Dr. George Tidmarsh as Executive Director

Isis Biopolymer Appoints New President and CEO

RedHill Biopharma Appoints Key Opinion Leader Professor David Y. Graham from Baylor College of Medicine, Houston, Texas, as Lead Investigator for the US Pivotal Clinical Trial with RedHill's Crohn’s Drug – RHB-104

Apceth is Extending its Top Management: Prof. Ralf Huss Moves from Roche (RHHBY) to the Biotechnology Company apceth

BioIndustry Association Board Appointments

>> More in: Appointments

Recognitions

Journal names discovery that HIV treatment can prevent spread 'breakthrough of the year'

Abbott Laboratories's Absorb(TM) Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award

Chris Henney Receives 2011 Hall of Fame Award at Annual Biotech CEO Meeting at Laguna Beach

Scripps Florida Scientist Awarded $2.2 Million Grant To Study Hepatitis C

SAMHSA Awards Up To $25 Million To Expand Use Of Health Information Technology

Ablitech, Inc. Awarded $2 Million

The Michael J. Fox Foundation Awards AFFiRiS AG $1.5 Million for the Clinical Development of the First Parkinson's Disease Vaccine

SAMHSA Awards Grant To UCLA For Substance Abuse Prevention In Iraq

KGI Professor Awarded Patent For Stem-Cell Therapy Aiding Heart-attack Patients

Nobel Prize for chemistry 2011 goes to Israeli scientist Daniel Shechtman

>> More in: Recognitions